BRCA1 and neoplasm: Among the 74 tumor samples harboring VUS only, 36 (48.6%) cases had alterations in BRCA1, 37 (50%) tumors had VUS in BRCA2 and one case (1.4%) presented VUS in both BRCA1 and BRCA2 genes (Figure 1).